MarketInOut Stock Screener Log In | Sign Up

Ixico Plc

LSE • Healthcare • Biotechnology • Quote as of 10/27/2026 16:55
Ixico Plc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeLSE
Market Capitalization21.9 mln
Float141 mln
Earnings Date12/08/2026

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.77
Likely reliable

Relative Strength

100 / 100
Top performer

Debt / Equity

0.05
Debt-free

Pre-Tax Margin

-43%
Deeply loss-making

ROE

-15.69
Negative

Business Description

IXICO plc is a London-based company that helps pharmaceutical businesses run more effective clinical trials by collecting, managing, and analyzing brain imaging data. Using its AI-powered platform, the company turns complex neurological data into clear, actionable insights for researchers studying conditions such as Alzheimer's, Parkinson's, Huntington's, and Multiple Sclerosis. IXICO works with clients across the United States, United Kingdom, and Europe, offering a full range of support services from trial management to regulatory reporting.

Key Fundamentals

EPS-2.00
ROE-15.69
RPS0.08
ROIC-17.56
ROA-13.33
Interest Cover-124
EBITDA, mln-2.67
EV / EBITDA-5.73
EV / EBIT-4.89
Revenue, mln7.28
EV / Revenue2.10

Quote Details

Last 11.75
Change 0.78 (7.11%)
Open 11.00
Volume 703,944
Turnover 8,271,342
Average Volume 177,039

Financial Ratios

Pre-Tax Profit Margin-43
Leverage Ratio1.21
Current Ratio2.83
Price / Book0.65
Price / Tangible Book1.88
Debt / Equity0.05
Price / Sales0.95

Financial Strength

Altman Z-Score-3.62
Piotroski F-Score 6 / 9
Beneish M-Score-2.77
Price to Intrinsic Value0.68

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 31.28% 100 / 100   
1 Month 61.85% 100 / 100   
2 Months 44% 98 / 100   
6 Months 74.07% 98 / 100   
1 Year 6.82% 47 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog